Aplisens SA (APN) Fair Value & Analysis
Technology · PL · Market cap 217M PLN (≈ $58.3M) · ISIN PLAPLS000016
What is Aplisens SA really worth?
A solid business, trading 34% below our fair value of 31.10 PLN.
Strengths
Risks
For context
Fair value as of: Aug 13, 2026
From 25 valuation models · updated 22 days ago
Fair value updated Aug 13, 2026, revised from 27.40 PLN to 31.10 PLN (+13.5%) since Jul 16, 2026. Share price +1.5% over the past month.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- The price is below even our cautious bear case (21.48 PLN). The market is more pessimistic than our downside scenario.
- Solid quality (64/100) at a price below fair value, the discount is the argument here, not the business quality.
- A fairly wide model range (21.48 PLN to 42.47 PLN) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range 8.75 PLN – 22.76 PLN · fair‑value band 21.48 PLN – 42.47 PLN · the 20.60 PLN price screens below the 31.10 PLN fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.
Analysis
Aplisens SA (APN) currently trades at 20.60 PLN, while our model-based Fair Value estimate is 31.10 PLN, implying the stock looks roughly 33.8% undervalued today. The Quality Score stands at 64/100 (solid quality), in the Technology sector. Bull case: the Growth Earnings group reads highest at a median of 32.33 PLN per share, and 17 of the 25 models we run sit above the 20.60 PLN price. Bear case: the Dividend Discount group reads lowest at 7.10 PLN, and 8 of the 25 models stay below the price. Evidence for this calculation is high.
Over the trailing twelve months, Aplisens SA generated revenue of 147M PLN at a net margin of 10.4%. Revenue declined 0.1% year over year. It earns a return on equity of 6.7%. The balance sheet holds a net cash position of 14.6M PLN. Fundamentals as of Aug 13, 2026
Our scenario range runs from 21.48 PLN (bear case) to 42.47 PLN (bull case); at 20.60 PLN, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades near its 52-week high and 24% above its 52-week low, currently above its 200-day average. For context, the median of 10 Technology peers we cover trades at −55% fair-value upside, at 51%, APN screens cheaper than that median.
Fair Value models
This estimate rests on fiscal year 2025 figures, and about 8 months have passed since. In that time the company retained roughly 0.3451 PLN per share, which is 1.1 % of the fair value. The fair value deliberately does not add this in: the models value reported figures, not a projection.
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.
All 25 models by family
Widest divergence: Growth Earnings (32.33 PLN) versus Dividend Discount (7.10 PLN). Highest evidence: FCF DCF (80).
Notify me when APN reaches fair value
Put APN on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Free, no payment details. Unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 65 · Market factors (momentum, volatility) 75
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
Aplisens S.A. supplies industrial control and measurement equipment in Poland, European Union, CIS countries, the United States, Asia, and internationally.
Full company description
Aplisens S.A. supplies industrial control and measurement equipment in Poland, European Union, CIS countries, the United States, Asia, and internationally. The company offers pressure, differential pressure, and level transducers; depth and level probes; electromagnetic flowmeters; measuring orifices; temperature sensors and transducers; valves and mounting accessories; meters, controllers, and displays; power supplies, separators, and signal transducers; fuel level probes for trucks; positioners; and electric actuators. It also provides consulting services related to the applications of its manufactured equipment; and warranty and post-warranty services. Its products are primarily focused on electronic pressure and differential pressure measurement technology. Aplisens S.A. was founded in 1992 and is headquartered in Warsaw, Poland.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Aplisens SA reported revenue of 147M PLN in FY2025 versus 121M PLN in FY2021, a compound +4.8%/yr. Reported net income was 15.3M PLN in FY2025, compounding −3.0%/yr from FY2021.
of which total revenue +6.1 % · buybacks/dilution +2.1 %
Annual growth per factor. These are factors, not summands: multiplied they give the EPS growth rate, added they do not quite. Start and end points are 3-year averages (details on hover).
Watch APN: get an alert when its fair value changes →
Peer Group
Scientific & Technical Instruments · 164 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Scientific & Technical Instruments median · lower = cheaper
Strength profile in five axes (Snowflake)
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Scientific & Technical Instruments stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Keysight Technologies, Inc KEYS | $316.13 | $107.22 | −66% |
| Garmin Ltd GRMN | $309.98 | $139.44 | −55% |
| Teledyne Technologies Incorporated TDY | $607.87 | $488.95 | −20% |
| Chroma ATE Inc 2360 | 2,195 TWD | 322.57 TWD | −85% |
| Hexagon AB HEXAB | kr 99.00 | kr 74.09 | −25% |
| MKS Inc MKSI | $281.60 | $76.00 | −73% |
| AVIC Chengdu Aircraft Company 302132 | ¥60.00 | ¥24.39 | −59% |
| Fortive Corporation FTV | $61.54 | $33.48 | −46% |
| Trimble Inc TRMB | $56.99 | $34.12 | −40% |
| Cognex Corporation CGNX | $60.79 | $19.25 | −68% |
Compare Aplisens SA with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Technology stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Aplisens SA (APN) overvalued or undervalued?
What is the fair value of APN?
What is the quality score of APN?
What is the revenue of Aplisens SA (APN)?
What is the net profit margin of APN?
Does Aplisens SA pay a dividend?
Watch Aplisens SA in the live analysis
One click puts Aplisens SA on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.